Using AI to screen for opioid use disorder
- PMID: 40247114
- DOI: 10.1038/s41591-025-03673-z
Using AI to screen for opioid use disorder
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.Addict Sci Clin Pract. 2025 Jun 16;20(1):50. doi: 10.1186/s13722-025-00576-9. Addict Sci Clin Pract. 2025. PMID: 40524244 Free PMC article.
-
Opioid use disorder and role of yoga as an adjunct in management (OUDARYAM): Study protocol for a randomized controlled trial.Wellcome Open Res. 2024 Jan 3;9:4. doi: 10.12688/wellcomeopenres.19392.1. eCollection 2024. Wellcome Open Res. 2024. PMID: 39015614 Free PMC article.
-
A Scoping Review of Community Harm Reduction Strategies for Maternal and Fetal Opioid Impacts: Implications for Policy.Subst Use Addctn J. 2025 Jul;46(3):722-734. doi: 10.1177/29767342241312486. Epub 2025 Feb 28. Subst Use Addctn J. 2025. PMID: 40018841
-
The effect of digital devices screen use on intraocular pressure: A systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2025 Jun 18. doi: 10.1007/s00417-025-06876-9. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40531309
-
Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024.JHEP Rep. 2024 Sep 6;6(12):101209. doi: 10.1016/j.jhepr.2024.101209. eCollection 2024 Dec. JHEP Rep. 2024. PMID: 39583096 Free PMC article. Review.
References
-
- Afshar, M. et al. Nat. Med. https://doi.org/10.1038/s41591-025-03603-z (2025). - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources